We're hiring! Join our team and discover a fulfilling career in biotech. To explore our open positions and learn more about the opportunities available at Superluminal Medicines, please visit our careers page at: https://lnkd.in/eqj7kSh6 #SuperluminalMedicines #Hiring #BioTech
Superluminal Medicines Inc.
生物技术研究
Boston，Massachusetts 2,450 位关注者
Generative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created.
关于我们
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. The predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect. Our discovery engine is powered by an industry-leading, pharmacokinetic and toxicology in silico prediction capability. With a lead program candidate expected in the near term, our proprietary pipeline validates our platform with initial programs focused on high-value GPCR targets. We’re pleased to be backed by a strong network of investors including RA Capital Management, Insight Partners, NVentures, Catalio Capital Management, Eli Lilly and Company, Gaingels, and Cooley LLP.
- 网站
-
https://superluminalrx.com/
Superluminal Medicines Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
地点
-
主要
获取路线
15 Necco St
Lilly Gateway Labs, 4th Floor
US，Massachusetts，Boston，02210
Superluminal Medicines Inc.员工
动态
-
Proud to be included on CB Insights 2024 annual "Digital Health 50", a list of the world's most promising private digital health companies. We are ready for the new year, excited by our growing team, and energized with the work in front of us! Check out the article here: https://lnkd.in/enBp2xTt #SuperluminalMedicines #BioTech #DrugDiscovery #DigitalHealth?
-
-
Superluminal Medicines will be attending the 43rd?Annual J.P. Morgan Healthcare Conference this January in San Francisco! The team looks forward to connecting with global industry leaders and discussing the latest market trends and medical innovations. We will be onsite all week and look forward to seeing you at #JPM2025 #SuperluminalMedicines #JPMConference?
-
-
?? Big news at Superluminal Medicines! ?? We are thrilled to announce the closing of our $120 million Series A funding round, led by RA Capital Management, with participation from Insight Partners, nVentures (NVIDIA), Gaingels, and new investors Catalio Capital Management, Eli Lilly and Company, and Cooley LLP. This milestone marks a pivotal step in our mission to revolutionize drug discovery through generative biology, chemistry, and machine learning. This investment accelerates our mission to revolutionize drug discovery through our generative biology, chemistry, and machine learning platform. By focusing on GPCR-targeted therapies, we aim to transform how medicines are created with unprecedented speed and accuracy. We’re incredibly excited to continue our journey in transforming medicine and grateful for the support of our investors and incredible team! Stay tuned for more updates as we push the boundaries of drug discovery. ???? #SeriesAFunding #Biotech #DrugDiscovery #AI4DD #GPCR #Innovation #SuperluminalMedicines For more, check out our press release here: https://lnkd.in/eFTsSKgF
-
?? Exciting Announcement! ?? A big shoutout to our esteemed SAB member, Sandeep Menon - Chief Development Officer at Alnylam, who will be presenting at the International Bio Convention in San Diego! ??? Date: Wednesday, June 05, 2024 ?? Time: 1:45 PM - 2:45 PM ?? Presentation Title: The Oncology Endgame: Assemble and Shine with AI and Precision Medicine, or Lose Join us to explore the future of oncology with AI and precision medicine. Don't miss out on this insightful session! More details here: https://lnkd.in/e9ePiEyt #BioConvention2024 #PrecisionMedicine #AIinHealthcare #HealthcareInnovation #BioTech #HealthcareAI
-
The Align Summit is almost here! Superluminal is?delighted to be at the @MassBio 2024 Align Summit with insights by @McKinsey and @LocustWalk on April 25th. Register for a full day of panel discussions, presentations by seed/series A #biotech and emerging artificial intelligence/machine learning companies, plus lots of networking. Register here:?https://lnkd.in/euynZvkA #AlignSummit24 #AlignSummit #AIDrugDiscovery?????
-
On April 25th,?Superluminal?will be joining the presentation line up at the @MassBio 2024 Align Summit with insights by @McKinsey and @LocustWalk. Register and join us for a day full of partnering opportunities, presentations, and panels. Hope to see you there!?https://lnkd.in/euynZvkA?#AlignSummit24 #AlignSummit #AIDrugDiscovery??
-
Our Co-founder, Senior VP, and Head of Discovery, Ajay Yekkirala, PhD, took the stage to share his groundbreaking insights on "Advancing Generative Techniques to Acquire Previously Undrugged Targets and Address Currently Unmet Patient Needs." His presentation not only highlighted the innovative strategies and technologies Superluminal Medicines Inc is pioneering but also underscored our commitment to transforming patient care by unlocking the potential of GPCRs. We are proud to be at the forefront of this exciting journey, pushing the boundaries of science to better human health. A huge thank you to all the attendees, organizers, and fellow speakers for fostering such an enriching environment for collaboration and innovation. ?? March 5-7, 2024 | ??Boston, MA #GPCRSummit2024 #DrugDiscovery #Innovation #SuperluminalMedicines #Biotech #gpcr
-